Provided by Tiger Fintech (Singapore) Pte. Ltd.

InVivo Therapeutics

0.3207
+0.0000
Volume:- -
Turnover:- -
Market Cap:995.92K
PE:-0.09
High:0.3207
Open:0.3207
Low:0.3207
Close:0.3207
Loading ...
Mar 05, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 03, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 02, 2020

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Mar 02, 2020

Major Issues Report

Current report, item 8.01
Feb 24, 2020

Major Issues Report

[Amend] Current report, item 5.07
Feb 21, 2020

Public Prospectus

General form for registration of securities under the Securities Act of 1933
Feb 20, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Feb 20, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2020

Major Issues Report

Current report, items 3.03, 5.03, and 9.01
Feb 03, 2020

Major Issues Report

Current report, item 8.01
Jan 24, 2020

Major Issues Report

Current report, items 3.02, 5.02, 5.03, 5.07, and 9.01
Jan 16, 2020

Major Issues Report

Current report, item 3.01
Dec 10, 2019

Major Issues Report

[Amend] Current report, item 5.02
Nov 22, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Nov 21, 2019

Major Issues Report

Current report, items 1.01, 3.03, and 9.01
Nov 13, 2019

Correspondence

[Cover]Correspondence
Nov 12, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Nov 12, 2019

Major Issues Report

Current report, item 5.02
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Sep 27, 2019

Major Issues Report

Current report, items 5.02 and 9.01